Engineering Tools for the Development of Recombinant Lactic Acid Bacteria.

Area of Science:

• Microbiology
• Biotechnology
• Food Science

Background:

• Lactic acid bacteria (LAB) are widely used in food fermentation and recognized as safe (GRAS) for biotherapeutic applications.
• Recent studies highlight the potential of recombinant LAB for producing therapeutics like antibodies and vaccines, leveraging their natural secretion and anchoring mechanisms.
• Genetic manipulation of LAB is complex due to their Gram-positive nature, necessitating specialized genetic tools.

Purpose of the Study:

• To review and discuss various gene expression strategies for engineering Lactic acid bacteria.
• To highlight the challenges and advancements in genetic modification of LAB for biotherapeutic development.
• To provide insights into optimizing LAB for industrial and therapeutic applications.

Main Methods:

• Literature review of existing research on Lactic acid bacteria genetic engineering.
• Analysis of different gene expression systems applicable to LAB.
• Discussion of methods for overcoming genetic modification challenges in Gram-positive bacteria.

Main Results:

• Identification of several distinct approaches for controlling gene expression in engineered LAB.
• Demonstration of the feasibility of using LAB for producing recombinant therapeutic proteins.
• Understanding the specific genetic tool requirements for LAB engineering.

Conclusions:

• Lactic acid bacteria offer a promising platform for biotherapeutic production due to their safety and innate cellular machinery.
• Overcoming genetic modification hurdles is key to fully realizing the therapeutic potential of LAB.
• Further development of gene expression technologies will advance the use of LAB in red biotechnology and beyond.